Table 2.
Hemodynamic variables | Model | Optimal BP (n=837) | Prehypertension (n=821) | ISH (n=121) | IDH (n=44) | SDH (n=178) |
---|---|---|---|---|---|---|
Proximal aortic characteristic impedance (Zc), dyne* sec/cm5 | 1 | 72.4±13.6 | 74.3±1.3‡ | 97.7±3.4*†§|| | 70.0±5.6‡ | 79.0±28.4‡ |
2 | 72.3±13.7 | 74.3±1.3‡ | 98.2±3.5*†§|| | 70.0±5.6‡ | 79.3±2.9‡ | |
3 | 68.3±2.1 | 75.4±1.4‡|| | 103.2±4.0*†§|| | 75.4±6.0‡ | 88.9±4.8*†‡ | |
Aortic compliance, mm2/mmHg | 1 | 3.7±0.03 | 3.1±0.04*‡|| | 2.2±0.1*†§ | 3.0±0.2*‡|| | 2.2±0.1*†§ |
2 | 3.7±0.04 | 3.1±0.04*‡|| | 2.2±0.1*†§ | 3.0±0.2*‡|| | 2.4±0.1*†§ | |
3 | 3.5±0.1 | 3.1±0.04*‡ | 21.0±1.0*†§ | 3.3±0.2‡|| | 2.8±0.1*§ | |
Aortic distensibility, × 10−3 mmHg−1 | 1 | 6.3±0.1 | 4.9±0.1*‡|| | 3.7±0.2*† | 4.6±0.3*|| | 3.6±0.2*†§ |
2 | 6.3±0.1 | 4.9±0.1*‡|| | 3.7±0.2*† | 4.6±0.3*|| | 3.5±0.2*†§ | |
3 | 5.6±0.1 | 5.1±0.1* | 4.5±0.2* | 5.4±0.3 | 5.0±0.3 | |
Aortic arch pulse wave velocity, m/s | 1 | 4.2±0.1 | 4.6±0.1‡|| | 6.4±0.2*†§|| | 4.5±0.4‡|| | 5.6±0.2*†‡§ |
2 | 4.2±0.1 | 4.5±0.4‡|| | 6.4±0.2*†§ | 4.6±0.1‡|| | 5.7±0.2*†§ | |
3 | 4.3±0.1 | 4.6±0.1‡|| | 6.3±0.3*†§ | 4.4±0.4‡ | 5.5±0.3*† | |
Aortic size, mm2 | 1 | 641.7±5.2 | 670.2±5.0*|| | 692.1±13.1*|| | 697.4±21.3 | 759.3±10.8*†‡ |
2 | 641.8±5.2 | 670.3±5.0*|| | 689.7±13.1*|| | 698.4±21.3 | 760.8±10.9*†‡ | |
3 | 682.9±7.9 | 659.8±5.2 | 638.1±15.0 | 643.3±22.5 | 662.4±17.9 | |
Left ventricular stroke volume, ml | 1 | 73.4±0.5 | 73.2±0.5§ | 75.4±1.3§ | 66.3±2.1*†‡ | 70.9±1.1 |
2 | 73.2±0.5 | 73.3±0.5§ | 75.3±1.3§ | 66.9±2.1*†‡ | 71.1±1.1 | |
3 | 73.2±0.8 | 73.3±0.5§ | 75.3±1.5§ | 66.9±2.2†‡ | 71.2±1.8 | |
Systemic vascular resistance, dynes·s/cm5 | 1 | 1828.2±16.6 | 2061.6±16.0*§|| | 2175.2±42.0*§|| | 2406.3±68.4*†‡ | 2523.2±34.7*†‡ |
2 | 1834.1±16.6 | 2061.9±16.0*‡|| | 2177.0±42.0*|| | 2386.2±68.3*† | 2520.1±35.0*†‡ |
Adjusted means (±SE) in CMR-derived measures by each BP group are shown. Each CMR-derived measure was analyzed as the outcome in separate models. Multivariable-adjusted linear regression models were used and multiple pairwise comparisons among the BP groups were conducted. As adjustment factors, Model 1 included demographic variables (age, sex, and race) + clinical characteristics at visit 3 (height, weight, heart rate, smoking, physical activity, total cholesterol, fasting glucose, and eGFR), Model 2 included demographic variables + clinical characteristics at visit 3 +VAT, and Model 3 included demographic variables + clinical characteristics at visit 3 +VAT+ mean arterial pressure. Mean arterial pressure was incorporated in the formula of systemic vascular resistance, and therefore, model 3 in systemic vascular resistance did not exist. P values were obtained by Bonferroni multiple pairwise comparison tests, and statistical significance was defined as P <0.05.
P<0.05 vs. optimal BP;
P<0.05 vs. prehypertension;
P<0.05 vs. ISH;
P<0.05 vs. IDH;
P<0.05 vs. SDH.
CMR indicates cardiovascular magnetic resonance; ISH, isolated systolic hypertension; IDH, isolated diastolic hypertension; SDH, systolic and diastolic hypertension; SE, standard error; SBP, systolic blood pressure; DBP, diastolic blood pressure; VAT, visceral adipose tissue; eGFR, estimated glomerular filtration rate.